Over 60% of U.S. adults have risk factors for type 2 diabetes, far more than current diabetes prevention programs can realistically serve. Since diabetes often develops gradually ...
A new study evaluating the role of acmopatide (CT-868), a once-daily dual glucagon-like peptide 1/gastric inhibitory polypeptide receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results